Multi-site Decision Impact Study for Decipher
NCT02034825 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2016-02-29
Summary
This prospectively designed retrospective clinical utility study will evaluate urologists' treatment recommendations before and after reviewing Decipher results for selected patient cases.
Conditions
Interventions
- OTHER
-
Decipher Questionnaire
Each participant will complete the pre and post-Decipher eCRQs for a minimum of 5 cases, and a maximum of 25 cases.
Sponsors & Collaborators
- collaborator OTHER
-
GenomeDx Biosciences Corp
lead INDUSTRY
Principal Investigators
-
Badani K Ketan, MD · Columbia University
-
Christine d Buerki, PhD · GenomeDx Biosciences Inc.
-
Vipul Patel, MD · AdventHealth
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2015-01-31
- Completion
- 2015-01-31
Countries
- United States
Study Locations
More Related Trials
-
Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers
NCT03585114 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing
NCT06785441 ·Status: RECRUITING
-
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores
NCT03495427 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Comprehensive Assessment of Cancer Theranostic Response
NCT06815354 ·Status: RECRUITING ·Phase: NA
-
Decision Navigation for Advanced Prostate Cancer Treatment Options Using mHealth
NCT03327103 ·Status: UNKNOWN ·Phase: NA
-
Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer
NCT03976843 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients
NCT03237026 ·Status: RECRUITING
-
Prostate Cancer Screening: Fostering Informed Decisions
NCT00196807 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Prostate MRI Before Prostate Biopsies
NCT02485379 ·Status: COMPLETED ·Phase: NA
-
Optimizing Positive Predicting Value of Prostate MRI
NCT05078359 ·Status: UNKNOWN
-
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing
NCT05497024 ·Status: RECRUITING
-
Decipher Lethal Prostate Cancer Biology - Urine Metabolomics
NCT03237702 ·Status: RECRUITING ·Phase: NA
-
Decision Support Tools for Men With Prostate Cancer- Clinical & Lifestyle Model
NCT02451345 ·Status: COMPLETED ·Phase: NA
-
Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors
NCT04340245 ·Status: ACTIVE_NOT_RECRUITING
-
A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer
NCT01858688 ·Status: COMPLETED ·Phase: NA
-
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
NCT03354416 ·Status: RECRUITING
-
Gallium-68 Citrate PET Used in Prostate Cancer
NCT02391025 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Promoting Shared-decision Making in Opportunistic Screening for Prostate Cancer
NCT05187949 ·Status: UNKNOWN
-
Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer
NCT01354951 ·Status: TERMINATED ·Phase: PHASE2
-
F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer
NCT03501940 ·Status: NO_LONGER_AVAILABLE
-
The Detection of Circulating Tumor Cells (CTCs) in Patients With Prostatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
NCT02450435 ·Status: COMPLETED
-
STUDY OF PREFERENCES IN MEN FACED WITH THE DIFFERENT TREATMENT OPTIONS FOR LOCALIZED PROSTRATE CANCER WITH A GOOD OR INTERMEDIATE PROGNOSIS
NCT02080793 ·Status: COMPLETED ·Phase: NA
-
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing
NCT04404894 ·Status: ACTIVE_NOT_RECRUITING
-
Shared Decision Making in Low Risk Prostate Cancer
NCT01673581 ·Status: WITHDRAWN
-
A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging
NCT03445559 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA